Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-15

Clinical Trial Update: Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1-2 study of vatalanib in combination with gemcitabine in advanced pancreatic cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemcitabine (Gemcitabine)
  • Vatalanib (vatalanib)

Snippet

Sponsor: George Albert Fisher | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-09-15